These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro.
    Author: Li W, Sanchez-Hidalgo A, Jones V, de Moura VC, North EJ, Jackson M.
    Journal: Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115355.
    Abstract:
    A number of inhibitors of the essential Mycobacterium tuberculosis mycolic acid transporter, MmpL3, are currently under development as potential novel antituberculosis agents. Using the checkerboard method to study the interaction profiles of various antituberculosis drugs or experimental compounds with two different chemotypes inhibiting this transporter (indolcarboxamides and adamantyl ureas), we showed that MmpL3 inhibitors act synergistically with rifampin, bedaquiline, clofazimine, and β-lactams.
    [Abstract] [Full Text] [Related] [New Search]